Company: LRHC
Filing Date: 2025-08-22
Form Type: 424B3
Source: 0001213900-25-079984
Chunk: 28

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-22
Form: 424B3
Chunk 28
---
 us to the Selling Stockholder may be
substantially less than the $150,000,000 total purchase commitment available to us under the Facility, which could materially adversely
affect our liquidity.

If it becomes necessary for us to issue and sell
to the Selling Stockholder shares of common stock in excess of the Exchange Cap under the Facility in order to receive additional gross proceeds up to $150,000,000
under the Facility, then for so long as the Exchange Cap continues to apply to the issuances and sales of our common stock under the Facility,
we must first obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap in accordance with the applicable
Nasdaq listing rules. Any issuance and sale by us under the Facility of shares of common stock in excess of the Exchange Cap could cause
additional substantial dilution to our stockholders. The number of shares of our common stock ultimately offered for sale by the Selling Stockholder is dependent
upon the number of shares of common stock, if any, we ultimately sell to the Selling Stockholder under the Facility, and the sale of common stock under the
Facility may cause the trading price of our common stock to decline.

Investors who buy shares at different times will likely pay different prices, and the sale of the shares of common stock acquired by the Selling Stockholder could cause the price of our common stock to decline.

Pursuant to the Facility, we will have discretion,
subject to market demand, to vary the timing, prices, and numbers of shares sold to the Selling Stockholder. If and when we do elect to sell shares of our
common stock to the Selling Stockholder pursuant to the Facility, after the Selling Stockholder has acquired such shares, the Selling Stockholder may resell all, some or none of such shares at
any time or from time to time in its discretion and at different prices. As a result, investors who purchase shares from the Selling Stockholder in this
offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and
in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value
of the shares they purchase from the Selling Stockholder in this offering as a result of future sales made by us to the Selling Stockholder at prices lower than the prices
such investors paid for their shares in this offering. Further, the sale of a substantial number of shares of our common stock by the Selling Stock